Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 21:11 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

ClinicalTrials.gov · NCT04717752 · Registry updated: 2021-01-28

Condition / research focus: Poor Ovarian Response
Sponsor: Nanjing University
Countries with listed sites: China
Registry dates and results: Start: 2021-01-20. Completion: 2021-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovidrel (drug)
Troprilin (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

ClinicalTrials.gov · NCT00700778 · Registry updated: 2021-01-25

Condition / research focus: BRCA1 Mutation; Breast Cancer
Sponsor: Fox Chase Cancer Center
Countries with listed sites: Austria · United States
Registry dates and results: Start: 2008-07. Completion: 2014-03 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

recombinant human chorionic gonadotropin (biological)
microarray analysis (genetic)
immunohistochemistry staining method (other)
laboratory biomarker analysis (other)
needle biopsy (procedure)

Where the study takes place — 3 listed sites

Mayo Clinic Cancer Center
Rochester, Minnesota, United States
Site recruitment: Not reported
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Universitaetsklinik fuer Frauenheilkunde
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Cost Effectiveness Analysis for Induction of Ovulation in the Polycystic Ovary Syndrome by Letrozole Versus Clomiphene Citrate

ClinicalTrials.gov · NCT04361175 · Registry updated: 2021-01-20

Condition / research focus: Infertility
Sponsor: Assiut University
Countries with listed sites: No country reported
Registry dates and results: Start: 2021-03. Completion: 2021-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (drug)
Clomiphine Citrate (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Normal Breathing and Swallowing in Healthy Volunteers

ClinicalTrials.gov · NCT03122145 · Registry updated: 2021-01-14

Condition / research focus: Healthy
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2017-05-23. Completion: 2019-02-28 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Capsaicin (drug) — also listed as: Reflexive Cough
Videofluoroscopic swallow study (device)

Where the study takes place — 1 listed sites

University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test

ClinicalTrials.gov · NCT04207554 · Registry updated: 2021-01-11

Condition / research focus: Pregnancy
Sponsor: Guangzhou Wondfo Biotech Co., Ltd
Countries with listed sites: United States
Registry dates and results: Start: 2019-12-05. Completion: 2020-12-29 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Test Device-Strip Format (device) — also listed as: Preview® hCG Urine/Serum Combo Pregnancy Test-Strip Format
Test Device-Cassette Format (device) — also listed as: Preview® hCG Urine/Serum Combo Pregnancy Test-Cassette Format
Predicate Device (device) — also listed as: QuickVue+ hCG Combo Test

Where the study takes place — 6 listed sites

National Insitute of Clinical Research
Garden Grove, California, United States
Site recruitment: Not reported
National Research Institute-Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
Downtown L.A. Research Center, Inc
Los Angeles, California, United States
Site recruitment: Not reported
National Research Institute-Westlake
Los Angeles, California, United States
Site recruitment: Not reported
National Research Institute-Panorama City
Panorama City, California, United States
Site recruitment: Not reported
National Research Institute-Santa Ana
Santa Ana, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia

ClinicalTrials.gov · NCT01718340 · Registry updated: 2021-01-08

Condition / research focus: Abortion, Habitual
Sponsor: Woman's Health University Hospital, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2012-06. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Metformin (drug) — also listed as: glucophage, cidophage, amophage

Where the study takes place — 1 listed sites

Women's Health Hospital
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Comparison of Follicle Diameter on hCG Day and Follicle Diameters on OPU (Oocyte Pick up) Day and the Effect of Follicle Diameters on Embryo Development and Pregnancy Outcomes

ClinicalTrials.gov · NCT04679688 · Registry updated: 2021-01-06

Condition / research focus: HCG Day Follicle Diameter, Reproduction Results
Sponsor: Acibadem University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2020-12-20. Completion: 2021-12-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

descriptive (other) — also listed as: The effect of follicle diameters on embryo development and pregnancy outcomes.

Where the study takes place — 2 listed sites

Acıbadem University Atakent Hospital
Istanbul, Küçükçekmece, Turkey (Türkiye)
Site recruitment: Recruiting
Acibadem MAA University Atakent Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Active, not recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore

ClinicalTrials.gov · NCT03291821 · Registry updated: 2020-12-29

Condition / research focus: Infertility, Female
Sponsor: IVI Madrid
Countries with listed sites: Spain
Registry dates and results: Start: 2017-12-01. Completion: 2020-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (12)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human menopausal gonadotropin (drug) — also listed as: menopur, meriofert
GnRH antagonist (drug) — also listed as: orgalutran, cetrotide
GnRH analog (drug) — also listed as: decapeptyl
Trophectoderm biopsy (procedure) — also listed as: embryo biopsy, blastocyst biopsy
MitoScore (diagnostic_test)
Intracytoplasmic sperm injection (procedure) — also listed as: ICSI
Ovarian puncture (procedure) — also listed as: pick up, egg retrieval
Preimplantation genetic test (diagnostic_test)
Embryo transfer (procedure)
Pregnancy test (diagnostic_test)
Embryo freezing (procedure) — also listed as: embryo cryopreservation, embryo vitrification
Embryo thawing (procedure)

Where the study takes place — 1 listed sites

IVI Madrid
Madrid, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

ClinicalTrials.gov · NCT01980680 · Registry updated: 2020-12-17

Condition / research focus: Infertility
Sponsor: Peter Humaidan
Countries with listed sites: Denmark
Registry dates and results: Start: 2014-12. Completion: 2020-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug)
Progesterone and Estradiol (drug)

Where the study takes place — 1 listed sites

The Fertility Clinic, Regional Hospital of Skive
Skive, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Efficacy and Safety of Vibrating Capsule in Patients With Functional Constipation

ClinicalTrials.gov · NCT04671264 · Registry updated: 2020-12-17

Condition / research focus: Functional Constipation; Gastrointestinal Disease; Capsule Endoscopy
Sponsor: Changhai Hospital
Countries with listed sites: China
Registry dates and results: Start: 2018-11-14. Completion: 2020-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sallowing VC during six weeks (device) — also listed as: Performing and reporting colonoscopy, Having laboratory examination, Filling diary cards, Evaluating the satisfaction

Where the study takes place — 1 listed sites

Changhai Hospital
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2RecruitingINTERVENTIONAL

Hyperpolarized Xenon-129 MR Imaging of the Lung

ClinicalTrials.gov · NCT04662658 · Registry updated: 2020-12-10

Condition / research focus: E-Cig Use
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2020-11-05. Completion: 2025-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hyperpolarized Xenon -129 MRI (drug) — also listed as: MRI with xenon-129 gas

Where the study takes place — 1 listed sites

Snyder Building 480 Ray C. Hunt Drive
Charlottesville, Virginia, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location

ClinicalTrials.gov · NCT02152696 · Registry updated: 2020-12-08

Condition / research focus: Persistent Pregnancy of Unknown Location; Ectopic Pregnancy
Sponsor: Yale University
Countries with listed sites: United States
Registry dates and results: Start: 2014-07-25. Completion: 2019-08-19 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Methotrexate (drug)
Uterine Evacuation (procedure)
Expectant Management (other)

Where the study takes place — 17 listed sites

University of California San Francisco
San Francisco, California, United States
Site recruitment: Not reported
Denver Health
Denver, Colorado, United States
Site recruitment: Not reported
Yale University
New Haven, Connecticut, United States
Site recruitment: Not reported
University of South Florida
Tampa, Florida, United States
Site recruitment: Not reported
Augusta University
Augusta, Georgia, United States
Site recruitment: Not reported
Northwestern University
Chicago, Illinois, United States
Site recruitment: Not reported
University Of Illinois at Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
Wayne State University
Southfield, Michigan, United States
Site recruitment: Not reported
Washington University
St Louis, Missouri, United States
Site recruitment: Not reported
University of Rochester
Rochester, New York, United States
Site recruitment: Not reported
University of North Carolina
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
Carolinas Medical Center - Women's Institute
Charlotte, North Carolina, United States
Site recruitment: Not reported
Duke University
Durham, North Carolina, United States
Site recruitment: Not reported
University of Oklahoma
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Greenville Health System
Greenville, South Carolina, United States
Site recruitment: Not reported
University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells

ClinicalTrials.gov · NCT04648566 · Registry updated: 2020-12-01

Condition / research focus: Infertility
Sponsor: Fertilys
Countries with listed sites: Canada
Registry dates and results: Start: 2017-03-22. Completion: 2020-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intrauterine administration of hCG-activated peripheral blood mononuclear cells (procedure)
Intrauterine administration of sperm washing medium (procedure)

Where the study takes place — 1 listed sites

Fertilys inc.
Laval, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

NMR Metabolomics Study of Follicular Fluid of Oncological Patients

ClinicalTrials.gov · NCT04101981 · Registry updated: 2020-11-24

Condition / research focus: Woman With Cancer Resorting Fertility Preservation
Sponsor: San Carlo Public Hospital, Potenza, Italy
Countries with listed sites: Italy
Registry dates and results: Start: 2016-05-01. Completion: 2018-05-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oocytes retrieval (procedure)

Where the study takes place — 1 listed sites

Angela Ostuni
Potenza, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

ClinicalTrials.gov · NCT01426386 · Registry updated: 2020-11-17

Condition / research focus: Infertility
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Belgium · Czechia · Denmark · Spain
Registry dates and results: Start: 2011-09. Completion: 2013-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FE 999049 (drug)
Gonal - F (drug)

Where the study takes place — 8 listed sites

UZ Brussel
Brussels, Belgium
Site recruitment: Not reported
UZ Gent
Ghent, Belgium
Site recruitment: Not reported
ICF CUBE
Prague, Czechia
Site recruitment: Not reported
Rigshospitalet
Copenhagen, Denmark
Site recruitment: Not reported
IU Dexeus
Barcelona, Spain
Site recruitment: Not reported
IVI Madrid
Madrid, Spain
Site recruitment: Not reported
IVI Sevilla
Seville, Spain
Site recruitment: Not reported
IVI Valencia
Valencia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Home Pregnancy Test Study on BioBank Samples

ClinicalTrials.gov · NCT04610632 · Registry updated: 2020-11-13

Condition / research focus: Pregnancy Related
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2020-11-09. Completion: 2020-11-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

home pregnancy test (diagnostic_test)

Where the study takes place — 1 listed sites

SPD Development Company Ltd.
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas MRI

ClinicalTrials.gov · NCT02995590 · Registry updated: 2020-11-04

Condition / research focus: Healthy Volunteers
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2016-07-01. Completion: 2021-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hyperpolarized He3 (drug) — also listed as: Helium study

Where the study takes place — 1 listed sites

University of Virginia
Charlottesville, Virginia, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT04610957 · Registry updated: 2020-11-02

Condition / research focus: Ovulation Induction; Polycystic Ovary Syndrome
Sponsor: FAlbasri
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-01-01. Completion: 2019-04-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Rosafem (FEMININE FORMULA) (drug)

Where the study takes place — 1 listed sites

Faculty of Medicine
Zagazig, Sharqia Province, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI

ClinicalTrials.gov · NCT04606082 · Registry updated: 2020-10-28

Condition / research focus: Fertility Disorders
Sponsor: Al-Azhar University
Countries with listed sites: No country reported
Registry dates and results: Start: 2020-10-30. Completion: 2021-01-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Granulocyte Colony Stimulated Factor (drug) — also listed as: GCSF, Neupogen, Granix and Zarxio
Human Chorionic Gonadotropins (drug) — also listed as: HCG, Novarel, and Pregnyl

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA).

ClinicalTrials.gov · NCT04605107 · Registry updated: 2020-10-27

Condition / research focus: Infertility, Female
Sponsor: Genuine Research Center, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-08-30. Completion: 2015-03-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Epifasi: Human chorionic gonadotrophin (drug) — also listed as: Epifasi
Pregnyl: Human chorionic gonadotrophin (drug) — also listed as: Pregnyl

Where the study takes place — 1 listed sites

Genuine Research Center GRC
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 21:11 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

ClinicalTrials.gov · NCT04717752 · Registry updated: 2021-01-28

Condition / research focus: Poor Ovarian Response
Sponsor: Nanjing University
Countries with listed sites: China
Registry dates and results: Start: 2021-01-20. Completion: 2021-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Ovidrel (drug)
Troprilin (drug)

Where the study takes place — 1 listed sites

Reproductive Medicine Center, The affiliated Drum Towel Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

ClinicalTrials.gov · NCT00700778 · Registry updated: 2021-01-25

Condition / research focus: BRCA1 Mutation; Breast Cancer
Sponsor: Fox Chase Cancer Center
Countries with listed sites: Austria · United States
Registry dates and results: Start: 2008-07. Completion: 2014-03 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

recombinant human chorionic gonadotropin (biological)
microarray analysis (genetic)
immunohistochemistry staining method (other)
laboratory biomarker analysis (other)
needle biopsy (procedure)

Where the study takes place — 3 listed sites

Mayo Clinic Cancer Center
Rochester, Minnesota, United States
Site recruitment: Not reported
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Universitaetsklinik fuer Frauenheilkunde
Vienna, Austria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Cost Effectiveness Analysis for Induction of Ovulation in the Polycystic Ovary Syndrome by Letrozole Versus Clomiphene Citrate

ClinicalTrials.gov · NCT04361175 · Registry updated: 2021-01-20

Condition / research focus: Infertility
Sponsor: Assiut University
Countries with listed sites: No country reported
Registry dates and results: Start: 2021-03. Completion: 2021-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole (drug)
Clomiphine Citrate (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Normal Breathing and Swallowing in Healthy Volunteers

ClinicalTrials.gov · NCT03122145 · Registry updated: 2021-01-14

Condition / research focus: Healthy
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2017-05-23. Completion: 2019-02-28 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Capsaicin (drug) — also listed as: Reflexive Cough
Videofluoroscopic swallow study (device)

Where the study takes place — 1 listed sites

University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Clinical Investigation for the Preview® hCG Urine/Serum Combo Pregnancy Test

ClinicalTrials.gov · NCT04207554 · Registry updated: 2021-01-11

Condition / research focus: Pregnancy
Sponsor: Guangzhou Wondfo Biotech Co., Ltd
Countries with listed sites: United States
Registry dates and results: Start: 2019-12-05. Completion: 2020-12-29 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Test Device-Strip Format (device) — also listed as: Preview® hCG Urine/Serum Combo Pregnancy Test-Strip Format
Test Device-Cassette Format (device) — also listed as: Preview® hCG Urine/Serum Combo Pregnancy Test-Cassette Format
Predicate Device (device) — also listed as: QuickVue+ hCG Combo Test

Where the study takes place — 6 listed sites

National Insitute of Clinical Research
Garden Grove, California, United States
Site recruitment: Not reported
National Research Institute-Huntington Park
Huntington Park, California, United States
Site recruitment: Not reported
Downtown L.A. Research Center, Inc
Los Angeles, California, United States
Site recruitment: Not reported
National Research Institute-Westlake
Los Angeles, California, United States
Site recruitment: Not reported
National Research Institute-Panorama City
Panorama City, California, United States
Site recruitment: Not reported
National Research Institute-Santa Ana
Santa Ana, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia

ClinicalTrials.gov · NCT01718340 · Registry updated: 2021-01-08

Condition / research focus: Abortion, Habitual
Sponsor: Woman's Health University Hospital, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2012-06. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Metformin (drug) — also listed as: glucophage, cidophage, amophage

Where the study takes place — 1 listed sites

Women's Health Hospital
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Comparison of Follicle Diameter on hCG Day and Follicle Diameters on OPU (Oocyte Pick up) Day and the Effect of Follicle Diameters on Embryo Development and Pregnancy Outcomes

ClinicalTrials.gov · NCT04679688 · Registry updated: 2021-01-06

Condition / research focus: HCG Day Follicle Diameter, Reproduction Results
Sponsor: Acibadem University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2020-12-20. Completion: 2021-12-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

descriptive (other) — also listed as: The effect of follicle diameters on embryo development and pregnancy outcomes.

Where the study takes place — 2 listed sites

Acıbadem University Atakent Hospital
Istanbul, Küçükçekmece, Turkey (Türkiye)
Site recruitment: Recruiting
Acibadem MAA University Atakent Hospital
Istanbul, Turkey (Türkiye)
Site recruitment: Active, not recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore

ClinicalTrials.gov · NCT03291821 · Registry updated: 2020-12-29

Condition / research focus: Infertility, Female
Sponsor: IVI Madrid
Countries with listed sites: Spain
Registry dates and results: Start: 2017-12-01. Completion: 2020-06-01 (may be estimated). No results posted in this registry response.

Products and interventions (12)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

human menopausal gonadotropin (drug) — also listed as: menopur, meriofert
GnRH antagonist (drug) — also listed as: orgalutran, cetrotide
GnRH analog (drug) — also listed as: decapeptyl
Trophectoderm biopsy (procedure) — also listed as: embryo biopsy, blastocyst biopsy
MitoScore (diagnostic_test)
Intracytoplasmic sperm injection (procedure) — also listed as: ICSI
Ovarian puncture (procedure) — also listed as: pick up, egg retrieval
Preimplantation genetic test (diagnostic_test)
Embryo transfer (procedure)
Pregnancy test (diagnostic_test)
Embryo freezing (procedure) — also listed as: embryo cryopreservation, embryo vitrification
Embryo thawing (procedure)

Where the study takes place — 1 listed sites

IVI Madrid
Madrid, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

ClinicalTrials.gov · NCT01980680 · Registry updated: 2020-12-17

Condition / research focus: Infertility
Sponsor: Peter Humaidan
Countries with listed sites: Denmark
Registry dates and results: Start: 2014-12. Completion: 2020-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug)
Progesterone and Estradiol (drug)

Where the study takes place — 1 listed sites

The Fertility Clinic, Regional Hospital of Skive
Skive, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Efficacy and Safety of Vibrating Capsule in Patients With Functional Constipation

ClinicalTrials.gov · NCT04671264 · Registry updated: 2020-12-17

Condition / research focus: Functional Constipation; Gastrointestinal Disease; Capsule Endoscopy
Sponsor: Changhai Hospital
Countries with listed sites: China
Registry dates and results: Start: 2018-11-14. Completion: 2020-10-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sallowing VC during six weeks (device) — also listed as: Performing and reporting colonoscopy, Having laboratory examination, Filling diary cards, Evaluating the satisfaction

Where the study takes place — 1 listed sites

Changhai Hospital
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2RecruitingINTERVENTIONAL

Hyperpolarized Xenon-129 MR Imaging of the Lung

ClinicalTrials.gov · NCT04662658 · Registry updated: 2020-12-10

Condition / research focus: E-Cig Use
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2020-11-05. Completion: 2025-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hyperpolarized Xenon -129 MRI (drug) — also listed as: MRI with xenon-129 gas

Where the study takes place — 1 listed sites

Snyder Building 480 Ray C. Hunt Drive
Charlottesville, Virginia, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location

ClinicalTrials.gov · NCT02152696 · Registry updated: 2020-12-08

Condition / research focus: Persistent Pregnancy of Unknown Location; Ectopic Pregnancy
Sponsor: Yale University
Countries with listed sites: United States
Registry dates and results: Start: 2014-07-25. Completion: 2019-08-19 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Methotrexate (drug)
Uterine Evacuation (procedure)
Expectant Management (other)

Where the study takes place — 17 listed sites

University of California San Francisco
San Francisco, California, United States
Site recruitment: Not reported
Denver Health
Denver, Colorado, United States
Site recruitment: Not reported
Yale University
New Haven, Connecticut, United States
Site recruitment: Not reported
University of South Florida
Tampa, Florida, United States
Site recruitment: Not reported
Augusta University
Augusta, Georgia, United States
Site recruitment: Not reported
Northwestern University
Chicago, Illinois, United States
Site recruitment: Not reported
University Of Illinois at Chicago
Chicago, Illinois, United States
Site recruitment: Not reported
Wayne State University
Southfield, Michigan, United States
Site recruitment: Not reported
Washington University
St Louis, Missouri, United States
Site recruitment: Not reported
University of Rochester
Rochester, New York, United States
Site recruitment: Not reported
University of North Carolina
Chapel Hill, North Carolina, United States
Site recruitment: Not reported
Carolinas Medical Center - Women's Institute
Charlotte, North Carolina, United States
Site recruitment: Not reported
Duke University
Durham, North Carolina, United States
Site recruitment: Not reported
University of Oklahoma
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Greenville Health System
Greenville, South Carolina, United States
Site recruitment: Not reported
University of Utah
Salt Lake City, Utah, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells

ClinicalTrials.gov · NCT04648566 · Registry updated: 2020-12-01

Condition / research focus: Infertility
Sponsor: Fertilys
Countries with listed sites: Canada
Registry dates and results: Start: 2017-03-22. Completion: 2020-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intrauterine administration of hCG-activated peripheral blood mononuclear cells (procedure)
Intrauterine administration of sperm washing medium (procedure)

Where the study takes place — 1 listed sites

Fertilys inc.
Laval, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

NMR Metabolomics Study of Follicular Fluid of Oncological Patients

ClinicalTrials.gov · NCT04101981 · Registry updated: 2020-11-24

Condition / research focus: Woman With Cancer Resorting Fertility Preservation
Sponsor: San Carlo Public Hospital, Potenza, Italy
Countries with listed sites: Italy
Registry dates and results: Start: 2016-05-01. Completion: 2018-05-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oocytes retrieval (procedure)

Where the study takes place — 1 listed sites

Angela Ostuni
Potenza, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

ClinicalTrials.gov · NCT01426386 · Registry updated: 2020-11-17

Condition / research focus: Infertility
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: Belgium · Czechia · Denmark · Spain
Registry dates and results: Start: 2011-09. Completion: 2013-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

FE 999049 (drug)
Gonal - F (drug)

Where the study takes place — 8 listed sites

UZ Brussel
Brussels, Belgium
Site recruitment: Not reported
UZ Gent
Ghent, Belgium
Site recruitment: Not reported
ICF CUBE
Prague, Czechia
Site recruitment: Not reported
Rigshospitalet
Copenhagen, Denmark
Site recruitment: Not reported
IU Dexeus
Barcelona, Spain
Site recruitment: Not reported
IVI Madrid
Madrid, Spain
Site recruitment: Not reported
IVI Sevilla
Seville, Spain
Site recruitment: Not reported
IVI Valencia
Valencia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Home Pregnancy Test Study on BioBank Samples

ClinicalTrials.gov · NCT04610632 · Registry updated: 2020-11-13

Condition / research focus: Pregnancy Related
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2020-11-09. Completion: 2020-11-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

home pregnancy test (diagnostic_test)

Where the study takes place — 1 listed sites

SPD Development Company Ltd.
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1UnknownINTERVENTIONAL

Assessing Deformable Image Registration in the Lung Using Hyperpolarized-gas MRI

ClinicalTrials.gov · NCT02995590 · Registry updated: 2020-11-04

Condition / research focus: Healthy Volunteers
Sponsor: University of Virginia
Countries with listed sites: United States
Registry dates and results: Start: 2016-07-01. Completion: 2021-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hyperpolarized He3 (drug) — also listed as: Helium study

Where the study takes place — 1 listed sites

University of Virginia
Charlottesville, Virginia, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome

ClinicalTrials.gov · NCT04610957 · Registry updated: 2020-11-02

Condition / research focus: Ovulation Induction; Polycystic Ovary Syndrome
Sponsor: FAlbasri
Countries with listed sites: Egypt
Registry dates and results: Start: 2019-01-01. Completion: 2019-04-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Rosafem (FEMININE FORMULA) (drug)

Where the study takes place — 1 listed sites

Faculty of Medicine
Zagazig, Sharqia Province, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI

ClinicalTrials.gov · NCT04606082 · Registry updated: 2020-10-28

Condition / research focus: Fertility Disorders
Sponsor: Al-Azhar University
Countries with listed sites: No country reported
Registry dates and results: Start: 2020-10-30. Completion: 2021-01-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Granulocyte Colony Stimulated Factor (drug) — also listed as: GCSF, Neupogen, Granix and Zarxio
Human Chorionic Gonadotropins (drug) — also listed as: HCG, Novarel, and Pregnyl

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA).

ClinicalTrials.gov · NCT04605107 · Registry updated: 2020-10-27

Condition / research focus: Infertility, Female
Sponsor: Genuine Research Center, Egypt
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-08-30. Completion: 2015-03-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Epifasi: Human chorionic gonadotrophin (drug) — also listed as: Epifasi
Pregnyl: Human chorionic gonadotrophin (drug) — also listed as: Pregnyl

Where the study takes place — 1 listed sites

Genuine Research Center GRC
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →